retatrutide triple agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research Retatrutide for weight loss: Study

We discuss long-term strategy from the start

Newer drugs like Mounjaro (Tirzepatide) combine GLP-1 and GIP (Glucose-Dependent Insulinotropic Peptide) effects

According to Lillys release, the trial met its primary endpoint: participants titrating up to the highest orforglipron dose lost 27.3 lb (12.4%) of body weight at 72 weeks versus about 0.9% weight loss with placebo

That is why I believe the story surrounding GLP-1s is still in its early chapters

In preclinical models, catestatin exhibits anti-inflammatory, antihypertensive, and metabolic effects, and reduced circulating levels have been associated with hypertension, obesity, and insulin resistance (Mahata et al., 1997)